Suzhou Longcore Biotechnology

Longcore Biotechnology is a clinical-stage biopharmaceutical company based in Suzhou, China, specializing in the development of innovative antibody therapeutics for autoimmune and inflammatory diseases. The company focuses on high-demand therapeutic areas including dermatology and respiratory medicine, with a pipeline centered on targeting key cytokines such as IL-17, IL-4Rα, and IL-5. Their lead programs are currently undergoing clinical evaluation in China for indications such as plaque psoriasis and atopic dermatitis. Longcore aims to provide high-quality, affordable biological treatments to address significant unmet medical needs in the Chinese and global markets.